ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/12/2026
Back to search
Official data from USPTO
APELLIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APELLIS
ST13
US500000090505497Class
10, 35, 36, 41, 44
Filing
90505497
Registration
7882746
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
08/12/2026
Trademark type
Word
Nice classes
10, 35, 36, 41, 44
Filing date
02/02/2021
Registration date
08/05/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2021
First use in commerce
06/01/2021
Drawing code
4
Owner type
03
Owner location
Waltham, MA, US
Examiner
KOPENSKI, CLAUDIA ANN
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Apellis Pharmaceuticals, Inc.
Representatives
John V. Hobgood, Esquire WILMER CUTLER PICKERING HALE AND DORR LLP
Technical classification
Nice Classes
Class 10Class 35Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Infusion pumps for measuring and delivering medication and fluids; medical needles; patient support kits for monitoring wellness and administering medication comprised of medical ice packsblankets for medical usepads impregnated with disinfectant preparationsocks and printed instructionaleducationalteaching material in the fields of medication administrationdisease awareness and patient wellness
Class 35
Business administration of patient assistance programs for providing prescription pharmaceuticals at reduced or no cost for eligible patients
Class 36
Patient assistance program support servicesproviding financial assistance for prescription pharmaceuticals at reduced or no cost for eligible patients; providing information about medication insurance coverageinsurance benefits verificationreimbursementpayer policies and patient financial assistance
Class 41
Educational servicesconducting workshops and educational demonstrations in the fields of patient educationhealth awareness and condition management
Class 44
Charitable servicespatient assistance program support services for providing prescription pharmaceuticals at reduced or no cost for eligible patients; providing information about medication and access to medical care
Publications
History of USPTO decisions and trademark events.
50 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/15/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/11/2025
IUAF
USE AMENDMENT FILED
03/14/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/14/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/25/2025
EX5G
SOU EXTENSION 5 GRANTED
02/24/2025
EXT5
SOU EXTENSION 5 FILED
01/13/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/13/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/24/2024
EX4G
SOU EXTENSION 4 GRANTED
07/11/2024
EXT4
SOU EXTENSION 4 FILED
07/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/16/2024
EX3G
SOU EXTENSION 3 GRANTED
01/12/2024
EXT3
SOU EXTENSION 3 FILED
01/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/14/2023
EX2G
SOU EXTENSION 2 GRANTED
07/12/2023
EXT2
SOU EXTENSION 2 FILED
07/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/14/2023
EX1G
SOU EXTENSION 1 GRANTED
01/12/2023
EXT1
SOU EXTENSION 1 FILED
01/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2022
PUBO
PUBLISHED FOR OPPOSITION
05/17/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2021
GNRT
NON-FINAL ACTION E-MAILED
09/08/2021
CNRT
NON-FINAL ACTION WRITTEN
09/08/2021
DOCK
ASSIGNED TO EXAMINER
08/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2021
NWAP
NEW APPLICATION ENTERED
02/05/2021
Continuous trademark protection
Get notified about every new filing that threatens APELLIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.